{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:47Z","timestamp":1786969667910,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Carcinoma breast is now one of the leading causes of cancer-related deaths in women. It is categorized into various subtypes based on molecular typing and immunohistochemistry. It is crucial to study these subtypes to ensure early diagnosis and treatment. Therefore, our study aims to assess the histopathological and molecular subtypes of invasive breast cancers and their association with E-Cadherin expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted on 90 cases of invasive breast carcinoma. Immunohistochemistry was performed for estrogen receptor (ER), progesterone receptor (PR), HER2\/neu, Ki-67, and E-Cadherin. Molecular subtypes were classified as Luminal A, Luminal B, HER2\/neu enriched, and Triple-negative. E-Cadherin expression was categorized as positive (2+\/3+) or negative (0\/1+). Associations were analyzed using Chi-square test, one-way analysis of variance, and independent t-test. A P &lt; 0.05 was considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>ER positivity was observed in 57.8%, PR in 44.4%, HER2\/neu in 21.1%, E-Cadherin positivity in 66.7%, and high Ki-67 (&gt;15%) in 52.2% of cases. Molecular subtypes included Luminal A (44.4%), Luminal B (16.7%), HER2\/neu enriched (14.4%), and Triple-negative (24.4%). Molecular subtype was significantly associated with lymph node involvement (P &lt; 0.001), lymphatic invasion (P &lt; 0.001), vascular invasion (P = 0.043), and perineural invasion (P &lt; 0.001). E-Cadherin expression showed strong association with molecular subtype (P &lt; 0.001). Loss of E-Cadherin was most frequent in Triple-negative tumors (81.8%) and HER2\/neu enriched tumors. E-Cadherin loss was significantly associated with larger tumor size (P = 0.029), higher Nottingham grade (P = 0.026), and ER negativity (P = 0.024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>E-Cadherin loss is significantly associated with aggressive molecular subtypes and adverse histopathological features in invasive breast carcinoma, suggesting its potential relevance as a marker of tumor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1936_25","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:00:20Z","timestamp":1786780820000},"page":"516-524","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["E-Cadherin expression and its association with molecular subtypes of breast cancers \u2013 A cross-sectional study"],"prefix":"10.4103","volume":"22","author":[{"given":"Vibha","family":"Tripathi","sequence":"first","affiliation":[{"name":"Department of Pathology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakriti","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita","family":"Bohara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.JAA.0000580524.95733.3d","article-title":"Overview of breast cancer","volume":"32","author":"Watkins","year":"2019","journal-title":"JAAPA"},{"issue":"(S2)","key":"R3-20260817","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y","article-title":"E-Cadherin and a-, \u00df- and y-catenin protein expression in relation to metastasis in human breast carcinoma","volume":"3","author":"Bukholm","year":"1998","journal-title":"J Pathol"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/32433","article-title":"A causal role for E-Cadherin in the transition from adenoma to carcinoma","volume":"392","author":"Perl","year":"1998","journal-title":"Nature"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/WMX7DRWTFVQP2LQT","article-title":"E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters","volume":"125","author":"Qureshi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/diagnostics12123093","article-title":"Allred scoring of ER-IHC stained whole-slide images for hormone receptor status in breast carcinoma","volume":"12","author":"Ahmad Fauzi","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mjafi.2015.11.007","article-title":"Interpretation of ER and Her2neu hormonal receptor in breast cancer","volume":"72","author":"Mukherjee","year":"2016","journal-title":"Med J Armed Forces India"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/jomfp.jomfp_310_21","article-title":"Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2\/neu, p53 and Ki67 in oral squamous cell carcinoma","volume":"26","author":"Mohanapure","year":"2022","journal-title":"J Oral Maxillofac Pathol"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"214","DOI":"10.14740\/wjon1426","article-title":"Epithelial-cadherin expression is associated with better recurrence-free and overall survival in invasive lobular breast cancer in Mexican Women","volume":"12","author":"Fernandez-Ferreira","year":"2021","journal-title":"World J Oncol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"155","DOI":"10.31557\/apjcb.2024.9.2.155-161","article-title":"Expression of Ki-67 and E-cadherin in triple negative breast cancer: A hospital based study","volume":"9","author":"Nishat","year":"2024","journal-title":"Asian Pac J Cancer Biol"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"99","DOI":"10.17511\/jopm.2021.i03.02","article-title":"Aberrant expression of E-cadherin in infiltrating ductal and lobular breast carcinomas and its correlation with clinicopathological parameters \u2013 A hospital-based study","volume":"7","author":"Thota","year":"2021","journal-title":"Trop J Path Micro"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"10434","DOI":"10.1038\/s41598-023-37012-4","article-title":"Association of quantitative analysis of intratumoral reduced E-cadherin expression with lymph node metastasis and prognosis in patients with breast cancer","volume":"13","author":"Meng","year":"2023","journal-title":"Sci Rep"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/MJBL.MJBL_1006_23","article-title":"E-cadherin expression in invasive mammary carcinoma","volume":"21","author":"Abdulrazaq","year":"2024","journal-title":"Med J Babylon"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"190","DOI":"10.18231\/j.ijcbr.14768.1766567188","article-title":"E-Cadherin expression and its clinicopathological correlation in invasive ductal carcinoma of the breast","volume":"12","author":"Sawant","year":"2025","journal-title":"Int J Clin Biochem Res"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"21","DOI":"10.25259\/FH_20230101_21","article-title":"Clinico Clinico-pathological Study of Breast Lesions with regard to ECadherin Immunoexpression as a biomarker in Breast Cancer Tumorigenesis and Disease Progression","volume":"1","author":"Nasrin","year":"2023","journal-title":"Future Health"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"189197","DOI":"10.1371\/journal.pone.0189127","article-title":"The prognostic role of tumor size in early breast cancer in the era of molecular biology","volume":"12","author":"Kasangian","year":"2017","journal-title":"PLoS One"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/FDHX-L92R-BATQ-2GE0","article-title":"Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications","volume":"115","author":"Acs","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13193-010-0010-1","article-title":"Expression of E-Cadherin in breast carcinomas and its association with other biological markers-a prospective study","volume":"1","author":"Chintamani","year":"2010","journal-title":"Indian J Surg Oncol"},{"key":"R20-20260817","first-page":"38","article-title":"Role of E-cadherin Expression in Breast Carcinoma","volume":"4","author":"Dhanya","year":"2018","journal-title":"J Med Sci"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/bcr309","article-title":"The E-cadherin\/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression","volume":"3","author":"Berx","year":"2001","journal-title":"Breast Cancer Res"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R23-20260817","first-page":"675051","article-title":"Cell proliferation (Ki-67) expression is associated with poorer prognosis in Nigerian compared to British breast cancer women","volume":"2013","author":"Agboola","year":"2013","journal-title":"Int Sch Res Notices"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1200\/JCO.2007.15.5986","article-title":"Prognostic significance of Nottingham histologic grade in invasive breast carcinoma","volume":"26","author":"Rakha","year":"2008","journal-title":"J Clin Oncol"},{"key":"R25-20260817","first-page":"1659","article-title":"Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma","volume":"16","author":"Yang","year":"2018","journal-title":"Oncol Lett"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12957-017-1210-8","article-title":"E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: Evidence from a retrospective study and meta-analysis","volume":"15","author":"Liu","year":"2017","journal-title":"World J Surg Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1936_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:25Z","timestamp":1786968085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1936_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1936_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}